Nuvation Bio annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Nuvation Bio Depreciation & Amortization Growth & History (NUVB)
Nuvation Bio's depreciation and amortization was $1.7M for fiscal 2025.
View full Nuvation Bio company overviewNuvation Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | $1.1M | +154.61% |
| 2024 | 2024-12-31 | $683,000 | $461,000 | +207.66% |
| 2023 | 2023-12-31 | $222,000 | $23,000 | +11.56% |
| 2022 | 2022-12-31 | $199,000 | $15,000 | +8.15% |
| 2021 | 2021-12-31 | $184,000 | $81,000 | +78.64% |
| 2020 | 2020-12-31 | $103,000 | — | — |
Nuvation Bio quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $536,000 | $180,000 | +50.56% |
| Q1 2026 | 2026-03-31 | $536,000 | $226,000 | +72.90% |
| Q4 2025 | 2025-12-31 | $539,000 | — | — |
| Q3 2025 | 2025-09-30 | $534,000 | $372,000 | +229.63% |
| Q2 2025 | 2025-06-30 | $356,000 | $112,000 | +45.90% |
| Q1 2025 | 2025-03-31 | $310,000 | $252,000 | +434.48% |
| Q3 2024 | 2024-09-30 | $162,000 | $107,000 | +194.55% |
| Q2 2024 | 2024-06-30 | $244,000 | $188,000 | +335.71% |
| Q1 2024 | 2024-03-31 | $58,000 | $2,000 | +3.57% |
| Q3 2023 | 2023-09-30 | $55,000 | −$1,000 | −1.79% |
| Q2 2023 | 2023-06-30 | $56,000 | $8,000 | +16.67% |
| Q1 2023 | 2023-03-31 | $56,000 | $10,000 | +21.74% |
| Q3 2022 | 2022-09-30 | $56,000 | −$14,000 | −20.00% |
| Q2 2022 | 2022-06-30 | $48,000 | $7,000 | +17.07% |
| Q1 2022 | 2022-03-31 | $46,000 | $16,000 | +53.33% |
| Q3 2021 | 2021-09-30 | $70,000 | $44,000 | +169.23% |
| Q2 2021 | 2021-06-30 | $41,000 | $15,000 | +57.69% |
| Q1 2021 | 2021-03-31 | $30,000 | $6,000 | +25.00% |
| Q3 2020 | 2020-09-30 | $26,000 | — | — |
| Q2 2020 | 2020-06-30 | $26,000 | — | — |
| Q1 2020 | 2020-03-31 | $24,000 | — | — |
Nuvation Bio depreciation and amortization trends
Over the last five fiscal years, Nuvation Bio's depreciation and amortization increased from $103,000 to $1.7M, a change of $1.6M. The latest reported quarter, Q2 2026, shows $536,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nuvation Bio source filings ↗